• E-mail
• Print
• Comment
• Font Size
• Digg
• del.icio.us
• Discuss article

The Most Efficient Way to Get Your Food and Drug Products to Market Within FDA Regulations

Posted on: Wednesday, 4 October 2006, 12:00 CDT

Research and Markets (http://www.researchandmarkets.com/reports/c43026) has announced the addition of Video Leadership Seminars: Getting a New Food & Drug Product to Market Within FDA Regulations With Charles Raubicheck of Frommer Lawrence & Haug LLP to their offering.

The goal of this Video Leadership Seminar is to provide you with critical information on getting a new food and drug product to the market within FDA regulations. The DVD is viewable on any computer or Video iPod and features 50 minutes of live video with Charles Raubicheck of Frommer Lawrence & Haug LLP sharing his best practices on various strategies and external factors that play into the legal issues involved with getting a new product to market. The Video Leadership Seminar provides an inside look at how one of the top food and drug lawyers goes about working with his clients to get new products to market in the timeliest and most efficient manner possible, providing ideas you can implement immediately.

Topics covered in the Video Leadership Seminar include:

1) A checklist of issues companies need to be aware of with respect to new food & drug products;

2) Understanding regulatory red flags and how to avoid them;

3) Step by step strategies for getting FDA and other regulatory approval;

4) Step-by-step negotiation strategies with the FDA;

5) Specific timelines and financials for the FDA approval process;

6) Case studies of how good negotiation strategies were implemented;

7) Areas in which companies and executives get into the most trouble with making poor expenditures;

8) Biggest mistakes for management teams to avoid;

9) A look back at FDA trends over the past five years;

10) Case studies of previous products and what worked and did not work when getting their product to market;

11) A future-oriented look at how the food & drug approval process is changing and how it will impact your process.

About Charles Raubicheck:

Charles Raubicheck is a partner in the New York office of Frommer Lawrence & Haug LLP. He is one of the country's foremost food and drug lawyers.

Mr. Raubicheck is an authority on pharmaceutical regulatory issues, with a focus on representing drug companies in matters before the FDA and in cases before the federal trial and appellate courts.

He also has experience in FDA regulatory matters involving foods, dietary supplements, cosmetics, medical devices, and biological products. In addition, he maintains an active trademark and advertising law practice for companies in FDA-regulated industries.

Mr. Raubicheck has taught Food and Drug Law for many years at New York University School of Law, and is a widely published author in the field. He has served as a member of the Editorial Advisory Board of the Food and Drug Law Journal and as Chair of the New York State Bar Associations Food, Drug and Cosmetic Law Section.

Following his legal education at Georgetown and service as a trial lawyer for the Food and Drug Administration, he has been engaged in private legal practice in the FDA and related fields for the past 25 years.

For more information visit http://www.researchandmarkets.com/reports/c43026

Source: Business Wire

More News in this Category